KEAP1 and infection: Briefly, Keap1, a specific repressor of Nrf2, can act as a sensor, directly binding EIAV-Rev upon EIAV infection and disrupting the binding of Keap1 and Nrf2, leading to the release and nuclear localization of Nrf2 and triggering the antioxidant response.